Shares of Pfizer (NYSE: PFE) climbed 4.2% on Tuesday after the pharmaceutical titan released its third-quarter results and boosted its full-year revenue and profit forecasts.
Pfizer's revenue soared 134% year over year in Q3 to $24.1 billion, propelled upward by $13 billion in COVID-19 vaccine sales.
"While we are proud of our third quarter financial performance, we are even more proud of what these financial results represent in terms of the positive impact we are having on human lives around the world," CEO Albert Bourla said in a press release.
Source Fool.com